
Canopus BioPharma Incorporated Share · US1380341032 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Canopus BioPharma Incorporated
No Price
Closing Price OTC 30.04.2026:
0,0001 USD
30.04.2026 20:00
Current Prices from Canopus BioPharma Incorporated
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
CBIA
|
USD
|
30.04.2026 20:00
|
0,0001 USD
| 0,00 USD |
Company Profile for Canopus BioPharma Incorporated Share
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.
Company Data
Name Canopus BioPharma Incorporated
Company Canopus BioPharma Incorporated
Website
https://www.blueheaven.cafe
Primary Exchange
UTC
ISIN US1380341032
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Patrick T. Prendergast
Country United States of America
Currency USD
Employees -
Address 233 Wilshire Boulevard, 90401 Santa Monica
IPO Date 1999-12-31
Stock Splits
| Date | Split |
|---|---|
| 16.07.2007 | 1:15 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | CBIA |
More Shares
Investors who hold Canopus BioPharma Incorporated also have the following shares in their portfolio:

